BlackRock Advisors’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $5.43M | Sell |
261,025
-24,445
| -9% | -$508K | 0.01% | 1069 |
|
|
2016
Q3 | $9.36M | Buy |
285,470
+8,783
| +3% | +$288K | 0.01% | 858 |
|
|
2016
Q2 | $6.91M | Buy |
276,687
+28,812
| +12% | +$719K | 0.01% | 954 |
|
|
2016
Q1 | $6.07M | Sell |
247,875
-293,176
| -54% | -$7.18M | 0.01% | 994 |
|
|
2015
Q4 | $17.9M | Sell |
541,051
-21,157
| -4% | -$699K | 0.02% | 576 |
|
|
2015
Q3 | $18.4M | Sell |
562,208
-123,536
| -18% | -$4.05M | 0.02% | 541 |
|
|
2015
Q2 | $36.3M | Buy |
685,744
+7,573
| +1% | +$401K | 0.04% | 368 |
|
|
2015
Q1 | $19.6M | Buy |
678,171
+279,229
| +70% | +$8.06M | 0.02% | 560 |
|
|
2014
Q4 | $11.6M | Sell |
398,942
-57,990
| -13% | -$1.69M | 0.01% | 717 |
|
|
2014
Q3 | $5.79M | Buy |
456,932
+7,931
| +2% | +$101K | 0.01% | 918 |
|
|
2014
Q2 | $9.01M | Buy |
+449,001
| New | +$9.01M | 0.01% | 794 |
|